Journal of Cancer
ISSN: 1837-9664
3.2
Impact Factor
ISSN: 1837-9664
Global reach, higher impactVolume 17 (1); 2026
Research Papers
Loss of CDKN2A/B is a Hallmark of RTK II Glioblastomas
Celina K. Langwieder, Dorothee Hölzl, Georg Hutarew, Hans U. Schlicker, Beate Alinger-Scharinger, Christoph Schwartz, Karl Sotlar, Theo F. J. Kraus
J. Cancer 2026; 17(1): 1-9. doi:10.7150/jca.122609
Full text
PDF
The Role of Inflammatory Biomarkers in PIPAC: Predicting Survival and Treatment Completion in Patients with Peritoneal Metastasis
Signe Roensholdt, Martin Graversen, Sönke Detlefsen, Claus Fristrup, Per Pfeiffer, Michael Bau Mortensen
J. Cancer 2026; 17(1): 10-20. doi:10.7150/jca.123687
Full text
PDF
Identification of key ferroptosis-related targets in colorectal cancer: A transcriptomics-driven study via machine learning and AUcell analysis of single-cell RNA-sequencing
Zhiqiang Liang, Zehui Hou, Zhuomin Yu, Bing Zeng, Fang Li, Jingjing Wu, Yingru Li, Zhipeng Jiang
J. Cancer 2026; 17(1): 32-48. doi:10.7150/jca.114522
Full text
PDF
Molecular Signature of Cisplatin Resistance in Ovarian Cancer Identifies Therapeutic Opportunities for Re-sensitization
Mahmoud Mansour, Sabrina van Ginkel, Maaz Alata, Ibrahim Bani, Isra Elhussin
J. Cancer 2026; 17(1): 49-58. doi:10.7150/jca.124252
Full text
PDF
Interleukin-17 receptor A drives cancer stem-like properties in colorectal cancer through STAT3 activation
Jeng-Kai Jiang, Chi-Hung Lin, Chun-Chi Lin, Liang-Chuan Lo, Po-Yen Sung, Zhen-Yu Wen, Chien-Ping Lin, Ting-An Chang, Chih-Yung Yang
J. Cancer 2026; 17(1): 74-85. doi:10.7150/jca.121654
Full text
PDF
Ganoderma microsporum Immunomodulatory Protein (GMI) Enhances Phagocytosis by Suppressing STAT3/CD47 Signaling in EGFR-Mutant NSCLC Resistant to Gefitinib and Osimertinib
Ya-Chu Hsieh, I-Lun Hsin, Ling-Yen Chiu, Yu-Chien Hung, Yu-Ting Kang, Hui-Yi Chang, Ching-Hsiung Lin, Jiunn-Liang Ko, Yu-Fan Liu
J. Cancer 2026; 17(1): 86-98. doi:10.7150/jca.124363
Full text
PDF
CES3 promotes NSCLC progression via lipid metabolic reprogramming regulated by TFAP2A
Pengfei Luo, Zirui Huang, Sijuan Ding, Zhangwen Tang, Yanhong Wei, Shaohui Jiang, Ruoting Tang, Fang Li, Han Yang, Lujun Zhao
J. Cancer 2026; 17(1): 99-108. doi:10.7150/jca.118395
Full text
PDF
Association of Ion Concentration with Immune-Related Adverse Events and Prognosis in Lung Cancer Patients Treated with PD-1/PD-L1 Inhibitors
Chen-Wei Liao, Juan Chen, Jia-Si Liu, Lei She, Ting Zou, Ya Wang, Zhan Wang, Zhao-Qian Liu
J. Cancer 2026; 17(1): 109-116. doi:10.7150/jca.120666
Full text
PDF
Disulfiram/Copper Combination as a Potential Therapeutic Approach for Hepatocellular Carcinoma: Targeting the ATF3-Mitochondrial Cell Death Pathway
Jing Cao, Jing Deng, Xinhua Li, Yaqiong Chen, Jialei Wang, Yutian Chong, Jiao Gong, Bingliang Lin
J. Cancer 2026; 17(1): 117-130. doi:10.7150/jca.113442
Full text
PDF
Sulforaphane-cysteine elicits apoptosis through JNK-mediated caspase activation in oral squamous cell carcinoma cells
Yen-Lin Chen, Yi-Tzu Chen, Wei-En Yang, Chun-Wen Su, Meng-Ying Tsai, Shih-Chi Su, Shun-Fa Yang, Chiao-Wen Lin
J. Cancer 2026; 17(1): 131-141. doi:10.7150/jca.126381
Full text
PDF
Reviews
Biomarkers for Recurrence and Prognosis in Metastatic Urothelial Cancer: Emerging Clinical Applications
Alicia Sánchez Cendra, Linda Rocio Ospino, Leonel Pekarek, Yumna Dbouk, Sami Chnaiker, Ana Luengo, Tania Villamor, Amalia Corralo, Raul Diaz-Pedrero, Laura Lopez-Gonzalez, Miguel A Saez, Majd N Michael Alhaddadin, María Belén Alonso-Bartolome, Carlos Casanova-Martín, Melchor Alvarez-Mon, Leonor Garcia Rodriguez, Silvestra Barrena-Blázquez, Miguel A Ortega
J. Cancer 2026; 17(1): 21-31. doi:10.7150/jca.123907
Full text
PDF
Cancer Cell Dormancy and Chemotherapy Resistance
Jingxian Hu, Wei Zhou, Ying Zhao, Peiran Li, Zhenying Zhao, Wei Wang, Wenhong Wang, Yijia Wang
J. Cancer 2026; 17(1): 59-73. doi:10.7150/jca.123742
Full text
PDF